Trial Profile
Phase IIa proof-of-concept, open-label study of extended-release metadoxine in adults with attention-deficit hyperactivity disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2013
Price :
$35
*
At a glance
- Drugs Metadoxine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Alcobra